BVBLAB SQUALAN SERUM STI CK 70

Manufacturer
FICC Co., Ltd. | Cosmax, Inc.
Effective date
2021-05-25
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 22:44:20

Label at a glance#

ProductBVBLAB SQUALAN SERUM STI CK 70
Active ingredientADENOSINE
Label structure9 sections

Indications and uses

■ Helps improve wrinkle problem

Dosage and administration

■ Apply evenly onto areas of concern.

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

ADENOSINE 0.04%

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Squalane, Polyethylene, Euphorbia Cerifera (Candelilla) Wax, Pyrus Malus (Apple) Seed Oil, Theobroma Grandiflorum Seed Butter, Triethylhexanoin, Citrus Aurantium Bergamia (Bergamot) Fruit Oil , Glycyrrhiza Glabra (Licorice) Root Extract ,Helianthus Annuus (Sunflower) Seed Oil, Citrus Nobilis (Mandarin Orange) Peel Oil, Plukenetia Volubilis Seed Oil, Hydrolyzed Hyaluronic Acid, Cucurbita Pepo (Pumpkin) Fruit Extract, Tremella Fuciformis (Mushroom) Extract, Camellia Sinensis Leaf Extract, Hydrolyzed Collagen, Tocopherol, Water, Butylene Glycol, Panthenol, Hydrogenated Lecithin, Stearic Acid, 1,2-Hexanediol, Soy Isoflavones,Ceramide AP, Ceramide AS, Ceramide EOP, Ceramide NP, Ceramide NS, Cholesterol, Phytosphingosine, Sodium DNA, Copper Tripeptide-1, Acetyl Hexapeptide-8, Cetearyl Alcohol, Limonene, Linalool

PURPOSE

OTC - PURPOSE SECTION

Anti wrinkle

WARNINGS

WARNINGS SECTION

For external use only
Consult a specialist if there are abnormal symptoms or side effects such as redness, swelling or itchiness due to direct sunlight during or after use.
Avoid using on wounded areas.
Keep out of reach of children

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN

Uses

INDICATIONS & USAGE SECTION

■ Helps improve wrinkle problem

Directions

DOSAGE & ADMINISTRATION SECTION

■ Apply evenly onto areas of concern.

Other Information

OTHER SAFETY INFORMATION

■ Keep away from direct sunlight.
■ The formulation may soften at a temperature of 113 or higher, but the content is still safe for use.
■ Contain plant-derived oil which may change in smell or color.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
81647-130-022023-10-17C16284748780-1f386c649-e81c-0266-e053-dadaa90a7c1a0ecd10e5-5988-46fe-8be0-84e383703d3b
81647-130-022023-01-30C16284748780-1f386c649-e81c-0266-e053-dadaa90a7c1a0ecd10e5-5988-46fe-8be0-84e383703d3b

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
81647-13081647-130-01, 81647-130-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
b9275b5c-6d1d-4e07-9ab0-68fd2d642cc10ecd10e5-5988-46fe-8be0-84e383703d3b2023-10-18WarningsExact identifier
spl set id: 0ecd10e5-5988-46fe-8be0-84e383703d3b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.